Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Fast and Easy Money in Penny Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Tracy Moore who wrote (2770)	8/24/2000 8:45:32 AM
From: StocksDATsoar	Respond to of 3517

In my opinion 11c for DNAP is a steal...I'm loading up today. DNAP IS NOT A BUY RECO BY ANY MEANS... ragingbull.altavista.com. By: mbeale4300 $$$ Reply To: None Thursday, 24 Aug 2000 at 8:37 AM EDT Post # of 4556 ********** New Investor DD *********** Everyone, copy and paste, add your own DD, and repost. DNAPrint Genomics (DNAP) used to be Catalyst Communications (CLYC) - both symbols are referenced here Do some DD, call the company Now! There is great info for those willing. Company Website: dnaprint.com Great News article that describes why this type of genomic research is the key. DNAPrint is one of a few labs actually doing this: doubletwist.com. ragingbull.altavista.com. The drug reaction/side effects problem is the genomics product that DNAPrint is targeting first. It is much bigger than what is described in the following article because most reactions are multiple gene related and DNAPrint is first (one of only three labs we know about) to do this. Whoever discovers the "multiple" gene combinations first (for each drug or disease) wins big in each "race". DNAPrint will use their combinatorial math platform and test other labs databases (those who do not know how to do the complex math) and they will share in the profits.: ragingbull.altavista.com. Important posts (add more): ragingbull.altavista.com. ragingbull.altavista.com. ragingbull.altavista.com. ragingbull.altavista.com. ragingbull.altavista.com. ragingbull.altavista.com. ragingbull.altavista.com. ragingbull.altavista.com. E-Mail interview with Dr. Frudakis: ragingbull.altavista.com. ragingbull.altavista.com. ragingbull.altavista.com. Info on O/S and Float: ragingbull.altavista.com. Local Newspaper Article: newscoast.com Press Releases: ragingbull.altavista.com. General Genomics Articles and Sites: sciam.com genomics.phrma.org 209.52.56.28 Investor Inquiries (Call the company Now!): DNAPrint Genomics, Sarasota Richard Craig Hall, 941/341-0136 ragingbull.altavista.com.